Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Pharmacotherapy
|
December 17, 1997
Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response
K M Sowinski, B S Burlew
Journal of Clinical Pharmacy and Therapeutics
|
July 24, 2004
Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection
K M Sowinski, M B Kays
Lancet (London, England)
|
September 26, 2001
Hyperkalaemia and apple juice
K M Sowinski, B A Mueller
The Annals of Pharmacotherapy
|
June 1, 1997
Ticlopidine and aspirin therapy following implantation of coronary artery stents
A G Hobson, K M Sowinski
Biochemical Pharmacology
|
November 14, 2001
Regulation of human beta(1)-adrenergic receptors and their mRNA in neuroepithelioma SK-N-MC cells: effects of agonist, forskolin, and protein kinase A
S W Bahouth, K M Sowinski, J J Lima
Pharmacotherapy
|
December 28, 1999
The effects of peracetic acid-hydrogen peroxide reprocessing on dialyzer solute and water permeability
M K Scott, B A Mueller, K M Sowinski
Clinical Pharmacology and Therapeutics
|
June 1, 1995
Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy men
K M Sowinski, B S Burlew, J A Johnson
Journal of Chromatography. B, Biomedical Sciences and Applications
|
April 25, 2001
Determination of albumin and myoglobin in dialysate and ultrafiltrate samples by high-performance size-exclusion chromatography
H Liang, M K Scott, D J Murry, et al.
Pharmacotherapy
|
April 22, 1999
Effect of gender on the pharmacokinetics of ofloxacin
K M Sowinski, S R Abel, W R Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 23, 1999
Dialyzer-dependent changes in solute and water permeability with bleach reprocessing
M K Scott, B A Mueller, K M Sowinski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Pharmacotherapy
|
December 17, 1997
Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response
K M Sowinski, B S Burlew
Journal of Clinical Pharmacy and Therapeutics
|
July 24, 2004
Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection
K M Sowinski, M B Kays
Lancet (London, England)
|
September 26, 2001
Hyperkalaemia and apple juice
K M Sowinski, B A Mueller
The Annals of Pharmacotherapy
|
June 1, 1997
Ticlopidine and aspirin therapy following implantation of coronary artery stents
A G Hobson, K M Sowinski
Biochemical Pharmacology
|
November 14, 2001
Regulation of human beta(1)-adrenergic receptors and their mRNA in neuroepithelioma SK-N-MC cells: effects of agonist, forskolin, and protein kinase A
S W Bahouth, K M Sowinski, J J Lima
Pharmacotherapy
|
December 28, 1999
The effects of peracetic acid-hydrogen peroxide reprocessing on dialyzer solute and water permeability
M K Scott, B A Mueller, K M Sowinski
Clinical Pharmacology and Therapeutics
|
June 1, 1995
Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy men
K M Sowinski, B S Burlew, J A Johnson
Journal of Chromatography. B, Biomedical Sciences and Applications
|
April 25, 2001
Determination of albumin and myoglobin in dialysate and ultrafiltrate samples by high-performance size-exclusion chromatography
H Liang, M K Scott, D J Murry, et al.
Pharmacotherapy
|
April 22, 1999
Effect of gender on the pharmacokinetics of ofloxacin
K M Sowinski, S R Abel, W R Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 23, 1999
Dialyzer-dependent changes in solute and water permeability with bleach reprocessing
M K Scott, B A Mueller, K M Sowinski, et al.
Page
of 2